DEVICE FOR DELIVERY OF MEDICAL DEVICES TO A CARDIAC VALVE

(19)

(11)

EP 2 946 751 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	31.07.2024 Bulletin 2024/31

(45)	Mention of the grant of the patent:
	26.06.2024 Bulletin 2024/26

(21)	Application number: 15156079.4

(22)	Date of filing: 07.05.2012

(51)

International Patent Classification (IPC):

A61F 2/24^(2006.01)
A61F 2/01^(2006.01)
A61M 25/10^(2013.01)

A61F 2/00^(2006.01)
A61M 25/04^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61F 2/243; A61F 2/2433; A61F 2250/0059; A61M 25/04; A61M 2025/1047; A61F 2002/016; A61F 2002/018; A61F 2230/0071; A61F 2/013; A61F 2/2427; A61F 2/011; A61F 2/014; A61F 2/012

(54)	DEVICE FOR DELIVERY OF MEDICAL DEVICES TO A CARDIAC VALVE VORRICHTUNG ZUR LIEFERUNG VON MEDIZINISCHEN GERÄTEN AN EINE HERZKLAPPE DISPOSITIF POUR LA MISE EN PLACE DE DISPOSITIFS MÉDICAUX SUR UNE VALVULE CARDIAQUE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

08.05.2011 EP 11165215
08.05.2011 US 201161483689 P

(43)	Date of publication of application:
	25.11.2015 Bulletin 2015/48

(60)	Divisional application:
	24184147.7

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	12718273.1 / 2693984

(73)	Proprietor: Emboline, Inc.
	Santa Cruz, CA 95060 (US)

(72)	Inventor:
	Krahbichler, Erik 25284 Helsingborg (SE)

(74)	Representative: KIPA AB
	Drottninggatan 11 252 21 Helsingborg 252 21 Helsingborg (SE)

(56)

References cited: :

WO-A1-00/43062
US-A1- 2008 147 160
US-A1- 2010 191 276

WO-A2-2011/132080
US-A1- 2009 030 510
US-A1- 2010 228 280

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).